-
Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations
25 Apr 2024 08:08 GMT
… and intracellular delivery of doxorubicin. ACS Appl Mater … chemotherapeutics to triple negative breast cancer cells and spheroids. … delivery of gemcitabine and doxorubicin. J Control Release. … the therapeutic index of doxorubicin for breast cancer. Eur Polym J …
-
EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer
20 Apr 2024 12:31 GMT
… pegylated liposomal doxorubicin HCl (PLD) in metastatic breast cancer after … targeting receptors on breast cancer for efficient delivery of … for HER2-positive breast cancer cells to achieve … are regulated by breast cancer-derived angiopoietin-like 7 …
-
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
12 Apr 2024 02:28 GMT
… -negative breast cancer, TNBC
Introduction
Triple-negative breast cancer (TNBC … breast cancer; a history of invasive breast cancer … , doxorubicin, and cyclophosphamide in node-positive breast cancer: … breast cancer: a SEER-Medicare study. Breast Cancer Res …
-
Adriamycin for Hodgkin Lymphoma May Increase Breast Cancer Risk
12 Apr 2024 00:12 GMT
… received Adriamycin (doxorubicin) may have an increased risk for breast cancer, according … the association between Adriamycin and breast cancer risk in Hodgkin … between [Adriamycin] and breast cancer and chest radiotherapy and breast cancer,” they …
-
Enalapril does not prevent chemotherapy-related heart damage in breast cancer, lymphoma
08 Apr 2024 22:18 GMT
… chemotherapy-related cardiotoxicity for breast cancer and lymphoma.
The … patients receiving treatment for breast cancer or lymphoma, according … doxorubicin-equivalent or more — for the treatment of breast cancer … -two percent had breast cancer while 38% had non …
-
Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials
08 Apr 2024 06:45 GMT
… during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin. BMJ Support Palliat … of aprepitant in patients receiving Adriamycin-cyclophosphamide-based chemotherapy. Support Care …
-
Two-Drug Combo Shows Promise as Treatment for Aggressive Form of Breast Cancer
02 Apr 2024 22:01 GMT
… triple-negative breast cancer. Overall, breast cancer is the most … treating triple-negative breast cancer because its cells … stage triple-negative breast cancer. Doxorubicin “is probably the … is on breast cancer, especially triple-negative breast cancer. Pitts …
-
Innovative Surgical Approaches That Improve Individual Outcomes in Advanced Breast Cancer
29 Mar 2024 14:19 GMT
… female breast cancer.1 In Romania, breast cancer registers … risk for advanced breast tumors is the appearance … advanced breast cancer and metastatic breast cancer.
Locally advanced breast cancer (LABC … node response to doxorubicin-based neoadjuvant chemotherapy …
-
Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues
27 Mar 2024 22:06 GMT
… such as triple negative breast cancer (TNBC) (Han … negative breast cancer (TNBC) cells were subjected to doxorubicin (DOX … breast cancer cells, NUPR1 upregulates p21 transcription, allowing breast cancer … myeloma, lymphoma, and breast cancers (Gong et al., …
-
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer
15 Mar 2024 09:12 GMT
… conferred resistance to doxorubicin and paclitaxel, but … profiling of 20q13-amplified breast cancers. Clin Cancer Res … to breast cancer risk and clinical outcome. Breast Cancer Res … transcriptomic architecture of 2000 breast tumours reveals novel subgroups. …